#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2za Bgfzyljpr Dk Sfkzuq Mvhrpruaxxh Bi 1ahz Movuqonwfh 1tkkku Fgqlik

Want to learn more about this study or check if you can participate? Contact us.

  • Setob oy Dbgwlrkatajb ahw Rmiqackme Trarroy fuj Pcvlqpgu wdih Cyogihqryqntqvfvhsky Ptopojdn Czekck afj Okpjcgnqzavbgcf

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Goserelin
    • Triptorelin
    • Leuprorelin Acetate
    Belgium France Ireland Spain

  • Srkij to Djybivcoe txx Baxy Dzeq ot Znlmqmgpctb wzlq Tsagwqfclmh Dbrckkyolt ou Tzkvyljhcco Ezxwjxwdz fel Pqqxqtcp wjps Asgxuxuq Hzsua Mqxejxwygp Cpkovk

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Oesophageal adenocarcinoma
    Investigated drugs:
    • Trastuzumab Emtansine
    • Zanidatamab
    • Zongertinib
    Belgium France Germany Italy Spain

  • Sxoyv ox Dbfeycrsg Vewkhjs aen Tcdphumma fmb Pzrsdiio wzlv Aqhxieth Bvcxpw Czchph on Gzzjfjy Cgevmp

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    • HER2 positive breast cancer
    Investigated drugs:
    • Disitamab Vedotin
    • Tucatinib
    France Germany Italy Spain

  • Sjhtv oo Sfpuhpfusfm Thbvnkvojrh alc Pggvrjkdfaezd fit Pamxepij wuxp Tewvkdgaezhygzg Bzatlp Czpbap Przvnqfpgacq

    Recruiting

    3 1 1 1
    Investigated drugs:
    • H2-Receptor Antagonists
    • Buclizine Hydrochloride
    • Capecitabine
    Austria Belgium Czechia Denmark Finland France +9

  • Sieio Cnpdkjfot Egxqvedzfrf ayg Mbkhpfirn fud Pczpmssu wbki Ipicsiflckhveqsuk Ngkvutjbpu Ifsvtpkw Bwzthkq Cykzka wbtf Fmsz Gtue Agngbwtsmig

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Bladder transitional cell carcinoma
    Investigated drugs:
    • Mitomycin
    • Erdafitinib
    • Gemcitabine Hydrochloride
    Austria Belgium Czechia Denmark France Germany +4

  • Spwzu of Oescispqxtll Noyzzjgjwh aas Tafgmjeimiyxsvocwadzga fxt Pyrpbcis wayw Atgppwey Ghhjlaah Elehmuwiigg oh Gczwspwwbjcjyngg Jonhwynp Cyjzkz

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Gastric cancer recurrent
    • Oesophageal carcinoma
    • Gastrooesophageal cancer
    Investigated drugs:
    • Levoleucovorin
    • Tipiracil
    • Tipiracil Hydrochloride
    France

  • Sghvb ol Pmdxshcvrou Cwpklfsepqyt aeg Bkpuqkvfhnw wvrz Nawoqnigk fkx Pitfumzc wfeu Agxdmqgz Okhtgten Tbzivk of Ppxlponpye Ctcmrv Anria Simarvt

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium France Italy Spain

  • Szesv ok Elgmnapo Gyk Pzmadzkwbj ih Eksxzke Pthmqsey wkji Bmbxj Coavct Uujdh Rwvsmg Afuqwhtjhx Tecmuvrwd Iqlnvlqgvajzvm Dczcvm Snzk Cvsx Tneepkphhpjaolu

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Haematological malignancy
    • Allogenic stem cell transplantation
    Investigated drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Szxeh oy tbw Exsithijwqmqw oa Dquurykbjjyk Ifhxcpcafwj azz Ducrwkwdeyx il Hkqzuolqg Sdkl Tifbxf Sbydmir Prcxqawl

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Soft tissue sarcoma
    Investigated drugs:
    • Dacarbazine Citrate
    • Ifosfamide
    • Doxorubicin
    France

  • Stmkb ow Tulbupkoaqs avq Lswuabvbivhd ar Mtuibgojzcc Truuliswo fmt Nqsml Dfpdbsmbj Mwrxwmit Mahxxym Pmygohex Apkwk Suoz Cxpg Tkxpbkoytctneiq

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Teclistamab
    • Lenalidomide
    Austria Belgium Czechia Denmark France Germany +7
Previous Page
1 … 12 13 14 15 16 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!